ATORVASTATIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 124 adverse event reports in the FDA FAERS database where ATORVASTATIN was used for Psoriasis.
Most Reported Side Effects for ATORVASTATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Type 2 diabetes mellitus | 7,556 | 9.5% | 84 | 166 |
| Myalgia | 7,155 | 9.0% | 233 | 1,230 |
| Drug hypersensitivity | 3,929 | 4.9% | 8 | 147 |
| Drug ineffective | 3,865 | 4.9% | 80 | 1,134 |
| Fatigue | 3,439 | 4.3% | 237 | 1,096 |
| Arthralgia | 3,338 | 4.2% | 239 | 642 |
| Rhabdomyolysis | 3,286 | 4.1% | 330 | 2,298 |
| Dyspnoea | 3,137 | 3.9% | 313 | 1,516 |
| Nausea | 2,888 | 3.6% | 237 | 1,298 |
| Asthenia | 2,791 | 3.5% | 291 | 1,200 |
| Headache | 2,747 | 3.5% | 228 | 940 |
| Pain | 2,700 | 3.4% | 20 | 1,000 |
| Malaise | 2,614 | 3.3% | 222 | 1,261 |
| Muscle spasms | 2,581 | 3.3% | 12 | 408 |
| Pain in extremity | 2,522 | 3.2% | 23 | 637 |
Other Indications for ATORVASTATIN
Product used for unknown indication (22,764)
Blood cholesterol increased (10,139)
Hypercholesterolaemia (5,615)
Dyslipidaemia (4,796)
Cardiovascular event prophylaxis (4,792)
Low density lipoprotein increased (4,713)
Hyperlipidaemia (3,648)
Blood cholesterol abnormal (2,024)
Blood cholesterol (1,722)
Blood triglycerides increased (1,638)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)